Get it on Google Play

FibroBiologics files IND with FDA for psoriasis therapy CYPS317

December 31, 2025 8:30 AM EST Send to a Friend
FibroBiologics Inc. (NASDAQ: FBLG) filed a Phase 1/2 Investigational New Drug application with the U.S. Food and Drug Administration seeking ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login